Urology Market Size, Share & Trends Analysis | China | 2020-2026 | MedSuite | Includes: Urinary Incontinence Market, Pelvic Organ Prolapse Repair Market, and 3 more
- Year: 2020
- Scope: 10 Years
- Region: China
- Pages: 369
- Published Date: 11/26/2019
- Type: MedSuite
In 2020, China’s urological device market size was valued at nearly $540 million, with over 2.4 million urological procedures performed every year. The market value is expected to increase at a compound annual growth rate (CAGR) of 1.7% to reach $605 million in 2026.
Throughout this medical market research, we analyzed 49 urology companies across China and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.
While this MedSuite report contains all of the Chinese Urological Device market data and analysis, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Urology Procedure Volumes
- Market Forecasts Until 2026, and Historical Data to 2016
- Competitive Analysis with Market Shares for Each Segment
- Market Drivers & Limiters for Each Urological Device market
- Recent Mergers & Acquisitions
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Market Value and Industry Trends
The stable growth across the market is driven by an increasing number of procedures performed, fueled by the growing geriatric population and the incidence rates of associated diseases, including urinary incontinence, pelvic organ prolapse, urolithiasis, nephrolithiasis and prostatic diseases. Moreover, complications of BPH treatment may result in urinary incontinence, providing a correlation between markets for the related treatment devices.
The urinary incontinence management device market, followed by the stone management device market and BPH treatment were the largest segments of the total market, accounting for the vast majority of the total market value in 2019. The growth of the urinary incontinence management device market is primarily driven by the catheter segment, which will account for the majority of the market growth. The growth in the stone management and BPH treatment device segments is driven by the stable demand for related procedures, the growing prevalence of prostatic and kidney diseases, and the premium prices for lasers and lithotripters.
By 2020, the leading competitor in the Chinese urology market was Boston Scientific. The company led the urinary incontinence management device market, pelvic organ prolapse repair market, stone management, and erectile dysfunction treatment market. The company’s leading position is attributed to its established products, including men’s health and prostate health businesses.
BARD was the second-leading competitor in the urological device market in China. This was attributed to the company’s notable presence in the urinary incontinence market, as well as its share of the pelvic organ prolapse repair and stone management device markets.
Accu-Tech held the third-leading share of the Chinese market by 2020, primarily attributed to its presence in the stone management device market and BPH treatment device market, the second and the third-largest segments of the total market.
Click on each title to view detailed market segmentation.
- Procedure Numbers for Urological Devices – MedPro – Discusses urological procedures performed in China. The analysis includes interventional benign prostatic hyperplasia (BPH) treatment, pelvic organ prolapse repair, stone management, urinary incontinence, and erectile dysfunction management procedures further broken down by device type.
- Urinary Incontinence Market – MedCore – In-depth analysis of the Urinary Incontinence Device Market. The chapter includes Urinary Catheter, Urethral Bulking Agent, and Incontinence Management device markets.
- Pelvic Organ Prolapse Repair Market – MedCore – The market is comprised of the segments for Transvaginal and Sacrocolpopexy Meshes.
- Stone Management Market – MedCore – This market is categorized by Device Type into ESWL Equipment, ISWL Equipment, Holmium Lasers, Stone Fragment Retrieval Device, Ureteral Stent, and Ureteral Guidewire market segments.
- BPH Treatment Market – MedCore – This market is segmented by Device Type, including Transurethral Resection of Prostate (TURP), Laser BPH, UroLift, and Rezūm devices.
- Erectile Dysfunction Market – MedCore – In-depth analysis of the Erectile Dysfunction device market. The chapter includes market segments, such as the Inflatable, Malleable, and Vacuum Erectile Dysfunction device markets.
Detailed Market Segmentation
DON’T SEE THE SEGMENT OR DATA YOU NEED?
Feel free to contact us or send a request by pressing one of the buttons below.
TABLE OF CONTENTS For the CHINA UROLOGY MARKET Report SuiteTABLE OF CONTENTS ILIST OF FIGURES XLIST OF CHARTS XIXEXECUTIVE SUMMARY 1CHINA UROLOGICAL DEVICE MARKET OVERVIEW 1COMPETITIVE ANALYSIS 3MARKET TRENDS 5MARKET DEVELOPMENTS 6PROCEDURE NUMBERS 7MARKETS INCLUDED 8VERSION HISTORY 9RESEARCH METHODOLOGY 10Step 1: Project Initiation & Team Selection 10Step 2: Prepare Data Systems and Perform Secondary Research 13Step 3: Preparation for Interviews & Questionnaire Design 15Step 4: Performing Primary Research 16Step 5: Research Analysis: Establishing Baseline Estimates 18Step 6: Market Forecast and Analysis 19Step 7: Identify Strategic Opportunities 21Step 8: Final Review and Market Release 22Step 9: Customer Feedback and Market Monitoring 23
DISEASE OVERVIEW2.1 BASIC ANATOMY 242.1.1 Urinary System 242.1.1.1 Male Urinary System 252.1.1.2 Female Urinary System 262.2 DISEASE TREATMENT AND DIAGNOSTICS 272.2.1 Benign Prostatic Hyperplasia 272.2.2 Urinary Incontinence 292.2.3 Urinary Tract Infections 312.2.4 Kidney Stones 322.2.5 Bladder Prolapse 342.2.6 Overactive Bladder 352.2.7 Prostatitis 362.2.8 Erectile Dysfunction 382.2.9 Cancer 402.2.9.1 Prostate Cancer 402.2.9.2 Bladder Cancer 412.2.10 Indications for Pelvic Organ Prolapse Repair 42
PRODUCT ASSESSMENT3.1 INTRODUCTION 443.2 PRODUCT PORTFOLIOS 443.2.1 Urinary Incontinence 4188.8.131.52 Urinary Catheters 4184.108.40.206.1 Intermittent Catheters 4220.127.116.11.2 Foley Catheters 418.104.22.168.3 Male External Catheters 422.214.171.124 Urethral Bulking Agents 4126.96.36.199 Incontinence Management Devices 4188.8.131.52.1 Female Incontinence Slings 4184.108.40.206.2 Male Implantable Devices 4220.127.116.11 Urine Bags 518.104.22.168.1 Leg Bags 522.214.171.124.2 Night Bags 513.2.2 Pelvic Organ Prolapse Repair 5126.96.36.199 Autologous Tissue as an Alternative to Vaginal Mesh 5188.8.131.52 Product Matrix for Pelvic Organ Prolapse Repair 583.2.3 Stone Management 5184.108.40.206 ESWL Equipment 5220.127.116.11 ISWL Equipment 603.2.3.3 Holmium Lasers 603.2.3.4 Stone Fragment Retrieval Devices 618.104.22.168 Ureteral Stents 613.2.4 BPH Treatment 622.214.171.124 TURP 6126.96.36.199 TUMT 6188.8.131.52 TUNA 6184.108.40.206 Prostatic Stents 6220.127.116.11 Laser BPH 618.104.22.168.1 Photoselective Vaporization of the Prostate (PVP) 622.214.171.124.2 Laser Vaporization of the Prostate 703.2.4.5.3 Laser Ablation of the Prostate 7126.96.36.199.4 Laser Resection of the Prostate 7188.8.131.52.5 Laser Enucleation of the Prostate 723.2.5 Erectile Dysfunction 7184.108.40.206 Penile Implants 7220.127.116.11.1 Inflatable 718.104.22.168.2 Malleable 722.214.171.124 Vacuum 753.3 REGULATORY ISSUES AND RECALLS 773.3.1 Boston Scientific 7126.96.36.199 Stone Management 7188.8.131.52 Nephrostomy 793.3.2 C. R. Bard (Becton Dickinson) 803.3.2.1 Urinary Incontinence 803.3.2.2 Stone Management 8184.108.40.206 Urological Endoscopes 8220.127.116.11 Prostate Cancer Treatment 818.104.22.168 Nephrostomy 863.3.3 Coloplast 822.214.171.124 Urinary Catheter 8126.96.36.199 Erectile Dysfunction 883.3.4 Cook Medical 8188.8.131.52 Stone Management 8184.108.40.206 Nephrostomy 903.3.5 Elekta 9220.127.116.11 Prostate Cancer Treatment 923.3.6 Karl Storz 918.104.22.168 Urological Endoscopes 933.3.7 Olympus 922.214.171.124 Urological Endoscopes 943.4 CLINICAL TRIALS 963.4.1 Boston Scientific 9126.96.36.199 Urinary Incontinence 9188.8.131.52 BPH Treatment 9184.108.40.206 Urological endoscopes 9220.127.116.11 Nephrostomy 918.104.22.168 Erectile Dysfunction 1003.4.2 C. R. Bard (Becton Dickinson) 1013.4.2.1 Urinary Incontinence 1013.4.2.2 Prostate Cancer Treatment 1033.4.3 Coloplast 1043.4.3.1 Urinary Incontinence 1043.4.4 Cook Medical 1073.4.4.1 Nephrostomy 1073.4.5 Elekta 1093.4.5.1 Prostate Cancer Treatment 1093.4.6 Ethicon 122.214.171.124 Urinary Incontinence 1113.4.7 Karl Storz 1126.96.36.199 Stone Management 1188.8.131.52 Urological Endoscopes 1153.4.8 Laborie 1184.108.40.206 Urodynamics 1183.4.9 Medline 1220.127.116.11 Urinary Incontinence 1203.4.10 Olympus 118.104.22.168 Stone Management 122.214.171.124 BPH Treatment 1126.96.36.199 Urological Endoscopes 123
CHINA UROLOGICAL DEVICE MARKET OVERVIEW4.1 INTRODUCTION 1254.2 CURRENCY EXCHANGE RATE 1274.3 MARKET OVERVIEW 1284.4 TREND ANALYSIS BY SEGMENT 1344.5 DRIVERS AND LIMITERS 1374.5.1 Market Drivers 1374.5.2 Market Limiters 1394.6 COMPETITIVE MARKET SHARE ANALYSIS 1434.7 MERGERS AND ACQUISITIONS 1524.8 COMPANY PROFILES 1544.8.1 Boston Scientific 1544.8.2 C. R. Bard (Becton Dickinson) 1564.8.3 Coloplast 1584.8.4 Cook Medical 1594.8.5 Ethicon 1604.8.6 Karl Storz 1614.8.7 Laborie 1624.8.8 Olympus 1634.9 SWOT ANALYSIS 1654.9.1 Boston Scientific 1664.9.2 C. R. Bard (Becton Dickinson) 1684.9.3 Coloplast 1704.9.4 Cook Medical 1714.9.5 Ethicon 1734.9.6 Karl Storz 1744.9.7 Laborie 1754.9.8 Olympus 176
PROCEDURE NUMBERS5.1 PROCEDURE OVERVIEW 1785.2 URINARY INCONTINENCE PROCEDURES 1835.2.1 Male Incontinence Management Procedures 1855.2.2 Female Incontinence Management Procedures 1875.3 PELVIC ORGAN PROLAPSE REPAIR 1905.4 STONE MANAGEMENT PROCEDURES 1925.4.1 ESWL Procedures 1945.4.2 Transurethral Procedures 1965.4.3 Ureteral Stent Placement Procedures 1985.4.4 PCNL Procedures 2005.5 BPH PROCEDURES 2025.6 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES 204
URINARY INCONTINENCE MANAGEMENT DEVICE MARKET6.1 INTRODUCTION 2066.2 MARKET OVERVIEW 2076.3 MARKET ANALYSIS AND FORECAST 2126.3.1 Total Urinary Catheter Market 2188.8.131.52 Intermittent Catheter Market 2184.108.40.206 Foley Catheter Market 2220.127.116.11 Male External Catheter Market 2196.3.2 Total Incontinence Management Device Market 218.104.22.168 Total Female Incontinence Sling Market 2246.3.2.1.1 Transvaginal Tape Female Incontinence Sling Market 2222.214.171.124.2 Transobturator Female Incontinence Sling Market 23126.96.36.199.3 Single-Incision Female Incontinence Sling Market 23188.8.131.52 Total Male Implantable Incontinence Device Market 23184.108.40.206.1 Male Incontinence Sling Market 2406.3.2.2.2 Male Artificial Urinary Sphincter Market 2426.3.3 Urethral Bulking Agent 2446.4 DRIVERS AND LIMITERS 2456.4.1 Market Drivers 2456.4.2 Market Limiters 2456.5 COMPETITIVE MARKET SHARE ANALYSIS 247
PELVIC ORGAN PROLAPSE REPAIR DEVICE MARKET7.1 INTRODUCTION 2527.2 MARKET OVERVIEW 2547.3 MARKET ANALYSIS AND FORECAST 2597.3.1 Total Pelvic Organ Prolapse Repair Device Market 2597.3.2 Transvaginal Mesh Market 2627.3.3 Sacrocolpopexy Mesh Market 2657.4 DRIVERS AND LIMITERS 2677.4.1 Market Drivers 2677.4.2 Market Limiters 2677.5 COMPETITIVE MARKET SHARE ANALYSIS 269
STONE MANAGEMENT DEVICE MARKET8.1 INTRODUCTION 2728.2 MARKET OVERVIEW 2748.3 MARKET ANALYSIS AND FORECAST 2808.3.1 ESWL Equipment Market 2808.3.2 ISWL Equipment Market 2838.3.3 Total Holmium Laser Market 28220.127.116.11 Holmium Laser Equipment Market 2818.104.22.168 Holmium Laser Fiber Market 2908.3.4 Total Stone Fragment Retrieval Device Market 2922.214.171.124 Nitinol Stone Fragment Retrieval Device Market 29126.96.36.199 Stainless Steel Stone Fragment Retrieval Device Market 3008.3.5 Ureteral Stent Market 3028.3.6 Ureteral Guidewire Market 3058.4 DRIVERS AND LIMITERS 3078.4.1 Market Drivers 3078.4.2 Market Limiters 3088.5 COMPETITIVE MARKET SHARE ANALYSIS 310
BPH TREATMENT DEVICE MARKET9.1 INTRODUCTION 3179.1.1 Treatments 3179.1.2 Comparison of TURP and Laser BPH Procedures 3199.1.3 Emerging Technologies 3199.2 MARKET OVERVIEW 3209.3 MARKET ANALYSIS AND FORECAST 3259.3.1 Total TURP Market 32188.8.131.52 Monopolar Electrode Market 32184.108.40.206 Bipolar Electrode Market 3309.3.2 Total Laser BPH Market 33220.127.116.11 Laser BPH Equipment Market 3318.104.22.168 Laser BPH Fiber Market 3379.3.3 UroLift® 3399.3.4 Rezūm® 3409.4 DRIVERS AND LIMITERS 3419.4.1 Market Limiters 3429.5 COMPETITIVE MARKET SHARE ANALYSIS 345
ERECTILE DYSFUNCTION DEVICE MARKET10.1 INTRODUCTION 35010.1.1 Low Testosterone Pharmaceutical Delivery 35110.2 MARKET OVERVIEW 35210.3 MARKET ANALYSIS AND FORECAST 35710.3.1 Inflatable Erectile Dysfunction Device Market 35710.3.2 Malleable Erectile Dysfunction Device Market 36010.3.3 Vacuum Erection Device 36210.4 DRIVERS AND LIMITERS 36310.4.1 Market Drivers 36310.4.2 Market Limiters 36310.5 COMPETITIVE MARKET SHARE ANALYSIS 365
iData’s 9-Step Research MethodologyOur reports follow an in-depth 9-step methodology which focuses on the following research systems:
- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.